Fineotex Chemical Limited — Q2 FY26 earnings call

Call held 10 Dec 2025

Management summary

Fineotex Chemical Limited announced the strategic acquisition of a 53.33% controlling stake in CrudeChem Technologies Group for $11.5 million. This move aims to significantly expand Fineotex's presence in the US oilfield specialty chemicals market, leveraging CrudeChem's $68 million annual revenue, R&D capabilities, and customer relationships. Management highlighted strong synergies, growth potential, and Fineotex's robust financial position to fund future expansions.

Highlights

  • Strategic acquisition of CrudeChem Technologies Group, a leading US-based specialty oilfield chemicals group, enhancing market presence in key US oilfield hubs.

  • Acquisition value of $11.5 million for a 53.33% stake in a company with USD 68 million annual revenue, deemed EPS-accretive.

  • Significant synergies expected through complementary product portfolios, accelerating technology transfer, co-development, and cross-selling opportunities.

  • CrudeChem is a profitable, debt-free company with strong R&D infrastructure and long-standing relationships with global energy producers.

  • Fineotex has strong financial liquidity with over ₹300 crores in cash, enabling funding of future investments without debt.

Concerns

  • Analyst questions regarding the low valuation ($22 million implied total for $68 million revenue) and whether CrudeChem was a distressed asset, which management denied.

  • The exact timeline for achieving the $200 million oilfield specialty chemicals vision is subject to geopolitical situations and crude oil price volatility.

  • CrudeChem's revenue has fluctuated in the past ($60M, $66M, $50M), indicating some market sensitivity.

Key financials

  1. CrudeChem Annual Revenue 68 Mn
  2. CrudeChem Acquisition Value 11.5 Mn
  3. CrudeChem Stake Acquired 53.3%
  4. CrudeChem Estimated EBITDA 4 Mn
  5. Fineotex Cash & Bank (Sep) ₹340 Cr
  6. North America Oilfield Market 11.5 Bn

What they filed

Q1 FY27: revenue up 175.2%, net profit up 92.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue146 126 120 137 138 −5%184 +46%314 +162%377 +175%
EBITDA36 34 21 25 31 −14%35 +3%44 +110%59 +136%
Net profit32 28 20 25 26 −19%30 +7%44 +120%48 +92%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Capital allocation

high confidence
  • Capex Capex disclosed entirely through internal accruals without debt
    • Plant and machinery investments in USA for CrudeChem $10 Mn
    So, it is not at all distressed. It's a profitable company, and there is a lot of value which we are bringing to the Company. We have, in fact, also, out of the $11.2-$11.5 million, almost $25 million to $30 million will be introduced in the Company as a primary issue, which will help for the growth of the company. Right now, the group has a huge orders in pipeline, and it is requiring capital to grow it up. Fineotex is the right match for us, and for the last, maybe at least two or three quarters, we have been discussing with this group on strategic alliances. We have already started doing some business with the Company even before, and we have understood the potential of each other working together in a synergy. It's not at all a distressed asset at all, and we are already planning a lot of executions of orders going forward.
  • Debt Debt disclosed
    It's a debt-free company.
  • M&A CrudeChem Technologies Group Acquisition · Closed · Consideration ₹[object Object] (cash)

    Strategic growth, deep penetration in US oilfield hubs, enhanced market presence, technology transfer, cross-selling opportunities, ESG-compliant solutions.

    EPS-accretive acquisition; will introduce $25-30 million as primary issue into CrudeChem for growth.

    So, Fineotex through its subsidiary has entered into a definitive agreement to acquire equity interest in four U.S.-based specialty chemical companies forming the CCT Technologies Group, the CrudeChem Technologies Group ecosystem, with a combined annual revenue of USD 68 million. Across these entities, Fineotex will acquire 53.33% controlling stake with a combined acquisition value of approximately $11.5 million, making this acquisition EPS-accretive.
  • Liquidity Cash ₹340 Cr Sufficient to cater to investments and working capital requirements for CrudeChem without raising debt.
    Yes. So Rohitji, as you might have seen, we have more than Rs. 300 crores plus in cash and bank at the moment, not at the moment, I mean, in a couple of quarters before, I mean, in the September results also, it must be around 340 if I'm not wrong. So yes, that is sufficient enough to cater and we will not have to go to raise any debt for the requirement of working capital or investments to be done in CrudeChem. So that's about it. So everything will be done with internal accruals and cash on bank, and it's much, much sufficient. And in fact, we are geared for more further investments in CCT or anything like that. We already have enough of cash on bank for that.

Guidance & targets

Business Growth

  • Oilfield Specialty Chemicals Business Size Business Growth · coming years (within 4 years) · High confidence $200 million
    This acquisition directly aligns with our strategic objective to build a $200 million business in oilfield Specialty Chemicals within the coming years.

    — Sanjay Tibrewala

Acquired Entity Growth

  • CrudeChem Technologies Group CAGR Growth Acquired Entity Growth · future · High confidence at least 25%
    In CCT, I'm very sure that we should be looking at at least 25% CAGR growth. Definitely, there's no doubt about it. So that's something which we should be expecting as what we are also expecting.

    — Sanjay Tibrewala

Acquisition Stake

  • Additional CrudeChem Stake Acquisition Acquisition Stake · January 2028 · High confidence another 25% (total 78.33%)
    No. Rather, we have got a commitment from them that at 2028, January, let's say 2 years from now, something like that, we will be having to get another 25% of it. So it will become 78.33.

    — Sanjay Tibrewala

What to watch in Q3 FY26

CrudeChem Financial Consolidation

next quarter
Current Acquisition closed, consolidation from Dec 15, 2025
Target Consolidated financials reflecting CrudeChem's contribution in Q1 FY27 (Jan-Mar 2026)

Why it matters

To assess the immediate financial impact and integration progress of the acquisition on Fineotex's consolidated results.

But if you see the real picture, I think the real picture, if you want to look at, I think the 1st January will be the most important thing because it's the yearend. US is always a little bit in a different mood as it goes towards the Christmas and the New Year. And so I think 1st January would be the best way to begin to see the differences in the consolidation.

Risks & concerns

  • Geopolitical situations and crude oil price volatility

    medium

    Geopolitical situations and crude oil price changes can impact the oil industry and the company's ability to achieve long-term targets.

    Management acknowledged

  • Integration challenges for acquired entities

    medium

    Integrating four US-based companies and accelerating technology transfer will require significant effort and planning, though management expressed confidence.

    Acknowledged

  • CrudeChem's past revenue fluctuations

    low

    CrudeChem's annual revenue has varied in the past ($60M, $66M, $50M), indicating sensitivity to market conditions, though management believes the current outlook is better.

    Management acknowledged

Q&A highlights

6 direct
CrudeChem valuation and distressed asset status Direct
So, it is not at all like this. Firstly, in the last two years, they have done almost, even in the last year, as you might have seen in the stock, the reporting which we have done, it is above 50, within one of the companies, $50 million, and the others have combined to the remaining ones. So, it is not at all distressed. It's a profitable company, and there is a lot of value which we are bringing to the Company.

Analyst questioned the low acquisition valuation relative to revenue, implying a distressed asset, which management strongly refuted by highlighting profitability, order pipeline, and capital needs.

Asked by Kautuk Yemdey

Consolidation timeline for acquired entity financials Partial
So possibly, if you ask us from the beginning, I think, let's say from 15th December would be a good...So let's say half of December would be in the consol. But if you see the real picture, I think the real picture, if you want to look at, I think the 1st January will be the most important thing because it's the yearend.

Clarified the immediate and effective dates for financial consolidation, important for investors modeling future results.

Asked by Anupam Agarwal

Synergies and cross-selling opportunities Direct
Fineotex is one of the best synergetic partners for CrudeChem because the products and the technologies Fineotex has is complementary to the range of CrudeChem. Now this is helping us instantly rather and that's what we have in fact began already about cross-selling and bringing our products to them.

Management detailed how Fineotex's product portfolio and financial strength complement CrudeChem's market position and customer base, driving immediate cross-selling.

Asked by Anupam Agarwal

Funding for future investments in CrudeChem Direct
Yes. So Rohitji, as you might have seen, we have more than Rs. 300 crores plus in cash and bank at the moment, not at the moment, I mean, in a couple of quarters before, I mean, in the September results also, it must be around 340 if I'm not wrong. So yes, that is sufficient enough to cater and we will not have to go to raise any debt for the requirement of working capital or investments to be done in CrudeChem.

Addressed concerns about funding future capex and working capital for CrudeChem, assuring investors that Fineotex's strong cash position negates the need for additional debt.

Asked by Rohit Sinha

Role of CrudeChem founders post-acquisition Direct
No, they are still the partners. Nobody's exiting out. We have acquired from each of them and equally. And also we have acquired, the company has also issued the shares. So it's something like that. So all of them will still be there. We are also there. And we'll collectively we'll be contributing the business, our best for the business.

Clarified that the experienced founders of CrudeChem will remain involved, ensuring continuity and leveraging their expertise for future growth.

Asked by Pratik Oza

Operational efficiencies and margin improvement for CrudeChem Direct
So I mean, there is a lot of operational benefits Fineotex will keep bringing in regularly. That's one. The overheads in such U.S. companies are generally higher than the way we are operating efficiencies, which you can see in India in Fineotex.

Management explained how Fineotex's operational expertise and financial support would improve CrudeChem's margins and overall ROCE, addressing a key analyst concern about profitability.

Asked by Siddharth Lakhanpal

Impact of crude oil price increases on business Direct
So, generally what we have experienced most of the times, all these suppliers of oil will have more businesses when the crude price goes up, the drilling, the oil recovery production, the Aramco's of the world globally, they have higher targets to produce more and more because the sales price are higher. That's the way it is.

Provided clarity on the relationship between crude oil prices and the company's business, indicating that higher prices generally lead to increased activity and volumes for oilfield chemical suppliers.

Asked by Devendra Singh

2 min read 5 chapters

Detailed narrative

Strategic Acquisition of CrudeChem Technologies Group

Fineotex Chemical Limited has acquired a 53.33% controlling stake in CrudeChem Technologies Group, comprising four U.S.-based specialty chemical companies, for approximately $11.5 million. This acquisition is considered EPS-accretive and aims to significantly enhance Fineotex's presence in the North American oilfield chemicals market, which is projected to be an $11.5 billion opportunity in 2025. CrudeChem Technologies Group reported a combined annual revenue of USD 68 million.

Synergies and Market Expansion

The acquisition is expected to unlock significant synergies, leveraging CrudeChem's robust R&D infrastructure in Texas and Fineotex's expertise in formulation chemistry to accelerate technology transfer and co-development of advanced chemistries. The complementary product portfolios will enable cross-selling across both customer bases, expanding Fineotex's reach in India, Asia, and North America. CrudeChem's established relationships with leading global energy producers provide immediate access to Tier 1 customers.

Growth Outlook and Financial Strength

Fineotex has set a strategic objective to build a $200 million business in oilfield Specialty Chemicals within the coming years. CrudeChem is projected to achieve at least 25% CAGR growth. Fineotex plans to acquire an additional 25% stake in CrudeChem by January 2028 at a future valuation, increasing its total holding to 78.33%. Fineotex maintains a strong financial position with over ₹300 crores (approximately ₹340 crores as of September results) in cash and bank, which is deemed sufficient to fund planned investments of over $10 million in CrudeChem's plant and machinery without incurring additional debt.

Operational Integration and Benefits

Fineotex expects to bring significant operational benefits to CrudeChem, addressing the generally higher overheads in US companies. The company plans to expand CrudeChem's capacity rapidly, including moving to new premises, to meet growing order volumes. Fineotex's support in working capital and raw material procurement is anticipated to improve CrudeChem's profitability and return on capital employed (ROCE).

Management's Perspective on Valuation

Management addressed analyst concerns regarding the acquisition's valuation, clarifying that CrudeChem is a profitable, debt-free company with significant growth potential and a strong order pipeline requiring capital infusion. The acquisition is not of a distressed asset, and the valuation reflects a strategic fit rather than a low price. Fineotex's long-standing growth (45% CAGR in last 5 years, 30% in last 14-15 years) and financial strength were key factors in the partnership.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Chemicals earnings calls